Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Veronica Balatti

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
Blood|September 23, 2018
<i>miR-125a</i> and <i>miR-34a</i> expression predicts Richter syndrome in chronic lymphocytic leukemia patientsVeronica Balatti, Luisa Tomasello, Laura Z Rassenti, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 20, 2017
<i>MicroRNA</i> dysregulation to identify therapeutic target combinations for chronic lymphocytic leukemiaLaura Z Rassenti, Veronica Balatti, Emanuela M Ghia, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 13, 2016
Dysregulation of a family of short noncoding RNAs, tsRNAs, in human cancerYuri Pekarsky, Veronica Balatti, Alexey Palamarchuk, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 23, 2023
Expression signature of human endogenous retroviruses in chronic lymphocytic leukemiaAlessandro La Ferlita, Giovanni Nigita, Liudmyla Tsyba, et al.
Blood|September 1, 2009
Karyotype-specific microRNA signature in chronic lymphocytic leukemiaRosa Visone, Laura Z Rassenti, Angelo Veronese, et al.
Journal of Cellular Physiology|January 11, 2020
Identification of tRNA-derived small RNA (tsRNA) responsive to the tumor suppressor, RUNX1, in breast cancerNicholas H Farina, Stephanie Scalia, Caroline E Adams, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 7, 2012
Tcl1 protein functions as an inhibitor of de novo DNA methylation in B-cell chronic lymphocytic leukemia (CLL)Alexey Palamarchuk, Pearlly S Yan, Nicola Zanesi, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 9, 2011
Mutated beta-catenin evades a microRNA-dependent regulatory loopAngelo Veronese, Rosa Visone, Jessica Consiglio, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 4, 2015
TCL1 targeting miR-3676 is codeleted with tumor protein p53 in chronic lymphocytic leukemiaVeronica Balatti, Lara Rizzotto, Cecelia Miller, et al.
Cancers|April 26, 2019
HNRNPL Restrains <i>miR-155</i> Targeting of BUB1 to Stabilize Aberrant Karyotypes of Transformed Cells in Chronic Lymphocytic LeukemiaSara Pagotto, Angelo Veronese, Alessandra Soranno, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Blood|September 23, 2018
<i>miR-125a</i> and <i>miR-34a</i> expression predicts Richter syndrome in chronic lymphocytic leukemia patientsVeronica Balatti, Luisa Tomasello, Laura Z Rassenti, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 20, 2017
<i>MicroRNA</i> dysregulation to identify therapeutic target combinations for chronic lymphocytic leukemiaLaura Z Rassenti, Veronica Balatti, Emanuela M Ghia, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 13, 2016
Dysregulation of a family of short noncoding RNAs, tsRNAs, in human cancerYuri Pekarsky, Veronica Balatti, Alexey Palamarchuk, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 23, 2023
Expression signature of human endogenous retroviruses in chronic lymphocytic leukemiaAlessandro La Ferlita, Giovanni Nigita, Liudmyla Tsyba, et al.
Blood|September 1, 2009
Karyotype-specific microRNA signature in chronic lymphocytic leukemiaRosa Visone, Laura Z Rassenti, Angelo Veronese, et al.
Journal of Cellular Physiology|January 11, 2020
Identification of tRNA-derived small RNA (tsRNA) responsive to the tumor suppressor, RUNX1, in breast cancerNicholas H Farina, Stephanie Scalia, Caroline E Adams, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 7, 2012
Tcl1 protein functions as an inhibitor of de novo DNA methylation in B-cell chronic lymphocytic leukemia (CLL)Alexey Palamarchuk, Pearlly S Yan, Nicola Zanesi, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 9, 2011
Mutated beta-catenin evades a microRNA-dependent regulatory loopAngelo Veronese, Rosa Visone, Jessica Consiglio, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 4, 2015
TCL1 targeting miR-3676 is codeleted with tumor protein p53 in chronic lymphocytic leukemiaVeronica Balatti, Lara Rizzotto, Cecelia Miller, et al.
Cancers|April 26, 2019
HNRNPL Restrains <i>miR-155</i> Targeting of BUB1 to Stabilize Aberrant Karyotypes of Transformed Cells in Chronic Lymphocytic LeukemiaSara Pagotto, Angelo Veronese, Alessandra Soranno, et al.
Pageof 5